Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 6/20 | 0.67 |
| ▸ | SERPINA6 | P08185 | 6/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.67 |
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 0.67 |
| ▸ | SHBG | P04278 | 4/20 | 0.67 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.67 |
| ▸ | PGR | P06401 | 3/20 | 0.67 |
| ▸ | AR | P10275 | 3/20 | 0.67 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3661927 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| SCHEMBL3509140 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| SCHEMBL5436459 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| SCHEMBL8069 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| SCHEMBL1457788 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| SCHEMBL571703 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| SCHEMBL25333984 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| SCHEMBL4747200 | 1.00 | CYP3A4 (0.67) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL3198033 | 0.99 | CYP3A4 (0.66) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR | |
| Bicarbonate SCHEMBL6684636 | 0.98 | CYP3A4 (0.65) | CYP3A4LMNASERPINA6SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2116249-B2 | Pharmaceutical compound containing gestagens and/or oestrogens and 5-methyl-(6S)-tetrahydrofolates | BAYER IP GMBH (DE) | 2023-04-05 | — | — | EP | claimed |
| EP-3544685-B1 | HETROARYLAMINE COMPOUNDS FOR MODULATING THE HEDGEHOG PATHWAY AND PREPARING METHOD AND USES THEREOF | DEV CT BIOTECHNOLOGY (TW) | 2023-01-04 | — | — | EP | claimed |
| EP-3411036-B1 | 3,5-DISUBSTITUTED PYRAZOLES USEFUL AS CHECKPOINT KINASE 1 (CHK1) INHIBITORS, AND THEIR PREPARATIONS AND APPLICATIONS | PHARMAENGINE INC (TW) | 2021-12-29 | — | — | EP | claimed |
| EP-3587406-B1 | 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER | FORMA THERAPEUTICS INC (US) | 2021-01-27 | — | — | EP | claimed |
| EP-3356305-B1 | POLYPHOSPHATE GLASS MICROSPHERES, METHODS OF MAKING AND USES THEREOF | UNIV DALHOUSIE (CA) | 2020-11-04 | — | — | EP | claimed |
| EP-2968316-B1 | 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER | FORMA THERAPEUTICS INC (US) | 2019-08-07 | — | — | EP | claimed |
| EP-2225235-B1 | THIAZOLE CARBOXAMIDE DERIVATIVES AND THEIR USE TO TREAT CANCER | MERCK SHARP & DOHME (US) | 2017-09-06 | — | — | EP | claimed |
| EP-1912658-B1 | THERAPEUTIC PROTOCOLS USING HYALURONAN | ALCHEMIA ONCOLOGY PTY LTD (AU) | 2017-01-25 | — | — | EP | claimed |
| EP-2820017-B1 | PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES | GENENTECH INC (US) | 2016-12-21 | — | — | EP | claimed |
| EP-2820008-B1 | AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES | GENENTECH INC (US) | 2016-12-14 | — | — | EP | claimed |
| EP-2032123-B1 | USE OF A HYDROPHILIC MATRIX COMPRISING A POLYACRYLIC ACID DERIVATIVE, A CELLULOSE ETHER AND A DISINTEGRANT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING FEMALE GENITAL DISORDERS | POLICHEM SA (LU) | 2010-01-20 | — | — | EP | claimed |
| EP-1888077-B1 | PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND/OR ESTROGENS AND 5-METHYL-(6S)-TETRAHYDROFOLATE | BAYER SCHERING PHARMA AG (DE) | 2009-04-29 | — | — | EP | claimed |
| EP-1462107-B1 | Method of female contraception and kit for use in such method | PANTARHEI BIOSCIENCE BV (NL) | 2008-09-24 | — | — | EP | claimed |
| EP-1313873-B1 | MODIFIED YEASTS AND USES THEREOF, IN PARTICULAR FOR PRODUCING STEROID DERIVATIVES | AVENTIS PHARMA SA (FR) | 2008-03-26 | — | — | EP | claimed |
| EP-1295600-B1 | Medicament based on gestagens for dermal application comprising ascorbic acid and/or salts thereof | KADE PHARMA FAB GMBH (DE) | 2006-04-05 | — | — | EP | claimed |
| EP-1293210-B1 | Means and method for hormonal contraception | PANTARHEI BIOSCIENCE BV (NL) | 2003-11-19 | — | — | EP | claimed |
| EP-0722720-B1 | Novel sugar coating composition for application to compressed medicinal tablets | AMERICAN HOME PROD (US) | 1999-10-13 | — | — | EP | claimed |
| EP-0491803-B1 | IMPLANTABLE DELIVERY DISPENSER | ALZA CORP (US) | 1994-07-20 | — | — | EP | claimed |
| EP-0500793-B1 | OSMOTIC, ORAL DOSAGE FORM FOR FERTILITY CONTROL | ALZA CORP (US) | 1993-11-03 | — | — | EP | claimed |
| EP-0472645-B1 | OSMOTIC DOSAGE FORM | ALZA CORPORATION (US) | 1993-07-14 | — | — | EP | claimed |